A primary cell-based in vitro model of the human small intestine reveals host olfactomedin 4 induction in response to Salmonella Typhimurium infection

Gut Microbes. 2023 Jan-Dec;15(1):2186109. doi: 10.1080/19490976.2023.2186109.

Abstract

Infection research largely relies on classical cell culture or mouse models. Despite having delivered invaluable insights into host-pathogen interactions, both have limitations in translating mechanistic principles to human pathologies. Alternatives can be derived from modern Tissue Engineering approaches, allowing the reconstruction of functional tissue models in vitro. Here, we combined a biological extracellular matrix with primary tissue-derived enteroids to establish an in vitro model of the human small intestinal epithelium exhibiting in vivo-like characteristics. Using the foodborne pathogen Salmonella enterica serovar Typhimurium, we demonstrated the applicability of our model to enteric infection research in the human context. Infection assays coupled to spatio-temporal readouts recapitulated the established key steps of epithelial infection by this pathogen in our model. Besides, we detected the upregulation of olfactomedin 4 in infected cells, a hitherto unrecognized aspect of the host response to Salmonella infection. Together, this primary human small intestinal tissue model fills the gap between simplistic cell culture and animal models of infection, and shall prove valuable in uncovering human-specific features of host-pathogen interplay.

Keywords: 3D tissue model; Intestinal enteroids; NOTCH; OLFM4; Salmonella Typhimurium; bacterial migration; bacterial virulence; biological scaffold; filamentous Salmonella Typhimurium; infection; olfactomedin 4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gastrointestinal Microbiome*
  • Humans
  • Intestine, Small
  • Salmonella Infections, Animal*
  • Salmonella typhimurium

Substances

  • olfactomedin

Grants and funding

The work was supported by the Deutsche Forschungsgemeinschaft (DFG) [270563345]. in the context of the GRK 2157. Furthermore, the DFG funded the SEM (JEOL JSM-7500F) [218894895] and the TEM (JEOL JEM 2100) [218894163]. T.D, A.-E.S., and O.D. thanks DFG for funding through GRK2157. A.-E.S. thanks DFG funding SFB1583 (DECIDE; Project B05). A.-E.S. thank the Single Cell Center Würzburg for support. T.K. thanks DFG funding via SFB1525 (Cardio-Immuno Interface: PS2 Project).